Breakthrough drug slashes chances of ovarian cancer returning

A breakthrough treatment for ovarian cancer slashes the chance of it returning, a study has found. Two thirds of patients given the drug during a trial had not relapsed within three years.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news